| Malignant neoplasm of prostate
Eligard vs Trelstar
Side-by-side clinical, coverage, and cost comparison for malignant neoplasm of prostate.Deep comparison between: Eligard vs Trelstar with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.Safety signalsTrelstar has a higher rate of injection site reactions vs Eligard based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Trelstar but not Eligard, including UnitedHealthcare
Sign up to reveal the full AI analysis
Category
Eligard
Trelstar
At A Glance
SC injection
Every 1-6 months
GnRH agonist
IM injection
Every 4-24 weeks
GnRH agonist
Indications
- Malignant neoplasm of prostate
- Malignant neoplasm of prostate
Dosing
Malignant neoplasm of prostate 7.5 mg SC once every month; 22.5 mg SC once every 3 months; 30 mg SC once every 4 months; 45 mg SC once every 6 months. Injection site should vary periodically in the upper- or mid-abdominal area, upper buttocks, or another location with adequate subcutaneous tissue.
Malignant neoplasm of prostate 3.75 mg by single IM injection every 4 weeks, 11.25 mg every 12 weeks, or 22.5 mg every 24 weeks; strengths are not additive and must be selected based on the desired dosing schedule.
Contraindications
- Hypersensitivity to GnRH, GnRH agonist analogs, or any component of ELIGARD
- Known hypersensitivity to triptorelin or any other component of the product, or other GnRH agonists or GnRH
Adverse Reactions
Most common (>2%) Hot flashes/sweats, malaise and fatigue, testicular atrophy, weakness, dizziness, nausea, urinary frequency, nocturia, pruritus, myalgia, gynecomastia, decreased libido
Injection site Transient burning/stinging, pain, erythema, bruising, pruritus, induration, ulceration
Postmarketing Pituitary apoplexy, convulsions, interstitial lung disease
Most common (>=1%) Hot flush, skeletal pain, headache, impotence/erectile dysfunction, hypertension, injection site pain, edema, dysuria, urinary tract infection, insomnia
Serious Tumor flare, hypersensitivity reactions, metabolic syndrome, cardiovascular disease, convulsions, severe cutaneous adverse reactions, QT/QTc prolongation, spinal cord compression
Postmarketing Pituitary apoplexy, cerebrovascular accident, myocardial infarction, pulmonary emboli, thromboembolic events, convulsions, non-alcoholic fatty liver disease, interstitial lung disease, SJS/TEN, DRESS, AGEP, erythema multiforme
Pharmacology
Leuprolide acetate is a GnRH agonist that potently inhibits gonadotropin secretion with continuous dosing; chronic administration suppresses LH and FSH, reducing testosterone to below castrate threshold (<=50 ng/dL) in males within two to four weeks of treatment initiation.
Triptorelin is a synthetic decapeptide GnRH agonist; chronic continuous administration suppresses LH and FSH secretion and markedly reduces testicular steroidogenesis, achieving medical castration levels of testosterone in men with advanced prostate cancer.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Eligard
- Covered on 5 commercial plans
- PA (12/12) · Step Therapy (0/12) · Qty limit (9/12)
Trelstar
- Covered on 5 commercial plans
- PA (12/12) · Step Therapy (0/12) · Qty limit (9/12)
UnitedHealthcare
Eligard
- Covered on 4 commercial plans
- PA (8/8) · Step Therapy (0/8) · Qty limit (2/8)
Trelstar
- Covered on 4 commercial plans
- PA (1/8) · Step Therapy (1/8) · Qty limit (1/8)
Humana
Eligard
- Covered on 0 commercial plans
- PA (2/3) · Step Therapy (0/3) · Qty limit (0/3)
Trelstar
- Covered on 0 commercial plans
- PA (3/3) · Step Therapy (0/3) · Qty limit (0/3)
Coverage data sourced from MMIT. Updated monthly.
Savings
Cost estimate not availableAssistance Fund: Prostate Cancer
Commercial or private insurance
Medicare, Medicaid, VA, TRICARE
Cost estimate not availableAssistance Fund: Prostate Cancer
Commercial or private insurance
Medicare, Medicaid, VA, TRICARE
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Next Steps for Your Patient
EligardView full Eligard profile
TrelstarView full Trelstar profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.